Atlantic Research Group (ARG) is a full-service Contract Research Organization providing expertise in therapeutic trials, clinical data and analytics, and pharmacoviligance services based in Charlottesville, VA. ARG is growing fast, expanding organizationally, and recently accepted a $3 million investment from undisclosed private investors with deep experience in healthcare services. Scale Finance advised on the transaction process supporting finance/accounting due diligence activities, negotiations, and transaction structuring. SF Managing Director Dave Gilroy and SF CFO Cheryl Hogan managed this work.
ARG understands the needs and the nature of innovative biopharmaceutical companies, and as their partner, provides a comprehensive array of services to meet their needs, from Phase 1 pharmacovigilance through post-confirmation and marketing. ARG matches the innovation of their clients with flexibility, responsive action, and personalized service.
Specific areas of clinical expertise offered by ARG include but are not limited to: Hematology/Oncology; Immunology/Allergy; Genetic Disorders/Rare Disease; Ophthalmology; CNS/Neurology; Infectious Disease; Metabolic Disease/Endocrinology.
Atlantic Research Group is fundamentally committed to agile and emerging biopharmaceutical innovators: these companies are all in – and so is ARG. ARG’s clinical experts are also experienced technologists – they have created a world class information system: TrialVista®, the industry’s most innovative CTMS. Clinical expertise, customized solutions – it’s the innovator’s clinical trial in the cloud. Atlantic Research Group prides itself on helping biopharma innovators get their new therapies to patients faster and more efficiently.
